Cargando…
Peptide redesign for inhibition of the complement system: Targeting age-related macular degeneration
PURPOSE: To redesign a complement-inhibiting peptide with the potential to become a therapeutic for dry and wet age-related macular degeneration (AMD). METHODS: We present a new potent peptide (Peptide 2) of the compstatin family. The peptide is developed by rational design, based on a mechanistic b...
Autores principales: | Mohan, Rohith R., Cabrera, Andrea P., Harrison, Reed E. S., Gorham, Ronald D., Johnson, Lincoln V., Ghosh, Kaustabh, Morikis, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082644/ https://www.ncbi.nlm.nih.gov/pubmed/27829783 |
Ejemplares similares
-
Virtual Screening of Chemical Compounds for Discovery of Complement C3 Ligands
por: Mohan, Rohith R., et al.
Publicado: (2018) -
Quantitative Modeling of the Alternative Pathway of the Complement System
por: Zewde, Nehemiah, et al.
Publicado: (2016) -
Role of Electrostatic Hotspots in the Selectivity of Complement Control Proteins Toward Human and Bovine Complement Inhibition
por: Narkhede, Yogesh B., et al.
Publicado: (2021) -
Electrostatic Interactions between Complement Regulator CD46(SCR1-2) and Adenovirus Ad11/Ad21 Fiber Protein Knob
por: Chen, Carl Z., et al.
Publicado: (2015) -
New Compstatin Peptides Containing
N-Terminal
Extensions and Non-Natural Amino Acids Exhibit Potent Complement Inhibition
and Improved Solubility Characteristics
por: Gorham, Ronald D., et al.
Publicado: (2014)